Ensign Peak Advisors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-41,530
| Closed | -$1.54M | – | 2137 |
|
|
2022
Q3 | $1.54M | Buy |
41,530
+41,170
| +11,436% | +$1.52M | ﹤0.01% | 878 |
|
|
2022
Q2 | $7K | Hold |
360
| – | – | ﹤0.01% | 2151 |
|
|
2022
Q1 | $10K | Hold |
360
| – | – | ﹤0.01% | 2189 |
|
|
2021
Q4 | $8K | Buy |
+360
| New | +$8K | ﹤0.01% | 2191 |
|
|
2021
Q1 | – | Sell |
-2,560
| Closed | -$82K | – | 1876 |
|
|
2020
Q4 | $82K | Sell |
2,560
-8,015
| -76% | -$257K | ﹤0.01% | 1789 |
|
|
2020
Q3 | $398K | Buy |
10,575
+4,165
| +65% | +$157K | ﹤0.01% | 1583 |
|
|
2020
Q2 | $287K | Buy |
+6,410
| New | +$287K | ﹤0.01% | 1543 |
|